Skip to market wire
InvestLog
← Back to Stock Events← 返回个股快讯
COREarnings Release财报快讯Media source媒体来源Source link原始来源by InvestLog AIInvestLog AI 整理
Event time: 事件时间：
Published: 文章发布：

COR earnings release — EPS beat +1.7% · revenue in line +0.5%Cencora, Inc. (COR) 财报发布 — EPS 高于预期+1.7% · 营收 基本符合预期+0.5%

Key Results

Actual vs Consensus

  • EPS: $4.66 vs $4.58 estimate, beat+1.7%.
  • Revenue: $88.4B vs $88.0B estimate, in line+0.5%.

    • Profitability and Cash Flow

  • Period: 2026 Q4 period ended 2026-09-30
  • Revenue: $88.4B; YoY: +5.5%; QoQ: +4.2%
  • Gross profit: $3.6B; Gross margin: 4.1%
  • Operating income: $907M; Operating margin: 1.0%; YoY: +6.1%; QoQ: -19.1%
  • Net income: $519M; GAAP diluted EPS: $2.71; YoY: +252.9%; QoQ: -32.0%
  • Operating cash flow: $3.1B; Capex: $398M; Free cash flow: $2.7B
  • Cash: $4.9B; Total debt: $11.3B; Net debt: $6.4B

    • Official release: Cencora Reports Fiscal 2026 Fourth Quarter and Fiscal Year End Results

    核心结果

    实际值与市场预期

  • EPS：$4.66 vs $4.58 预期，高于预期+1.7%。
  • 营收：$88.4B vs $88.0B 预期，基本符合预期+0.5%。

    • 财务指标

  • 期间：2026 Q4（截至 2026-09-30）
  • 营收：$88.4B；同比：+5.5%；环比：+4.2%
  • 毛利润：$3.6B；毛利率：4.1%
  • 经营利润：$907M；经营利润率：1.0%；同比：+6.1%；环比：-19.1%
  • 净利润：$519M；GAAP 稀释 EPS：$2.71；同比：+252.9%；环比：-32.0%
  • 经营现金流：$3.1B；资本开支：$398M；自由现金流：$2.7B
  • 现金：$4.9B；总债务：$11.3B；净债务：$6.4B
    • View COR stock details ->查看 COR 个股详情 ->

    For information only. Not investment advice.内容仅供参考，不构成投资建议。

    Related articles相关阅读

    COR signed an agreement to acquire American Oncology NetworkCencora, Inc.（COR）签约收购 American Oncology Network，尚未交割

    Material Company Event · October 21, 2026公司公告 · 2026/10/21

    COR plans to acquire American Oncology Network in $2.4 billion dealCencora, Inc.（COR）拟收购 American Oncology Network in $2.4 billion deal，尚未确认交割

    Material Company Event · October 21, 2026公司公告 · 2026/10/21

    COR regulated product launch: Cencora's Accelerate Pharmacy Solutions Launches Cell and Gene Therapy Enablement to Help Health Systems Build and Scale ProgramsCencora, Inc.（COR）正式推出获批药品或治疗产品

    Material Company Event · September 2, 2026公司公告 · 2026/9/2